VistaGen Therapeutics, Inc.
VTGN
$1.97
-$0.08-3.90%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -51.42M | -47.30M | -39.57M | -33.19M | -29.36M |
| Total Depreciation and Amortization | 635.00K | 616.00K | 598.00K | 580.00K | 568.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 3.93M | 3.62M | 3.15M | 2.76M | 2.19M |
| Change in Net Operating Assets | 4.76M | 4.05M | 2.33M | 1.06M | 793.00K |
| Cash from Operations | -42.10M | -39.02M | -33.49M | -28.79M | -25.81M |
| Capital Expenditure | -191.00K | -132.00K | -164.00K | -103.00K | -61.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -12.96M | -13.57M | -13.15M | -5.43M | -- |
| Cash from Investing | -13.15M | -13.70M | -13.31M | -5.53M | -61.00K |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | 0.00 | 1.00K | -784.00K | -985.00K |
| Issuance of Common Stock | 3.21M | 1.26M | 129.85M | 129.85M | 129.77M |
| Repurchase of Common Stock | -- | -380.00K | -380.00K | -380.00K | -380.00K |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -36.03M | -1.07M | 0.00 |
| Cash from Financing | 3.21M | 879.00K | 93.44M | 127.62M | 128.40M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -52.04M | -51.85M | 46.64M | 93.30M | 102.53M |